Shaanxi Kanghui Pharm Co Ltd (603139) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.010x

Based on the latest financial reports, Shaanxi Kanghui Pharm Co Ltd (603139) has a cash flow conversion efficiency ratio of 0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥7.14 Million ≈ $1.04 Million USD) by net assets (CN¥745.41 Million ≈ $109.08 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Shaanxi Kanghui Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Shaanxi Kanghui Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Shaanxi Kanghui Pharm Co Ltd total liabilities for a breakdown of total debt and financial obligations.

Shaanxi Kanghui Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shaanxi Kanghui Pharm Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Lendingtree Inc NASDAQ:TREE	0.218x
Yuanbao Inc. American Depositary Shares NASDAQ:YB	0.093x
GENERAL Elevator Co. Ltd. SHE:300931	0.001x
Betterware de MÃ©xico, S.A.P.I. de C.V. NASDAQ:BWMX	0.442x
RattanIndia Enterprises Limited NSE:RTNINDIA	0.010x
Tai-Tech Advanced Electronics Co Ltd TWO:3357	0.022x
Ways Electron Co Ltd SHG:605218	0.007x
Bank Maspion Indonesia PT JK:BMAS	0.007x

Annual Cash Flow Conversion Efficiency for Shaanxi Kanghui Pharm Co Ltd (2012–2024)

The table below shows the annual cash flow conversion efficiency of Shaanxi Kanghui Pharm Co Ltd from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see Shaanxi Kanghui Pharm Co Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥906.90 Million ≈ $132.71 Million	CN¥37.29 Million ≈ $5.46 Million	0.041x	+158.14%
2023-12-31	CN¥1.02 Billion ≈ $149.25 Million	CN¥-72.13 Million ≈ $-10.56 Million	-0.071x	-243.87%
2022-12-31	CN¥1.03 Billion ≈ $150.13 Million	CN¥50.43 Million ≈ $7.38 Million	0.049x	+638.84%
2021-12-31	CN¥1.12 Billion ≈ $163.16 Million	CN¥7.42 Million ≈ $1.09 Million	0.007x	-92.38%
2020-12-31	CN¥1.07 Billion ≈ $157.00 Million	CN¥93.72 Million ≈ $13.71 Million	0.087x	-17.40%
2019-12-31	CN¥1.02 Billion ≈ $148.79 Million	CN¥107.53 Million ≈ $15.73 Million	0.106x	+65.34%
2018-12-31	CN¥979.31 Million ≈ $143.30 Million	CN¥62.64 Million ≈ $9.17 Million	0.064x	+33.81%
2017-12-31	CN¥912.11 Million ≈ $133.47 Million	CN¥43.60 Million ≈ $6.38 Million	0.048x	-65.16%
2016-12-31	CN¥522.81 Million ≈ $76.50 Million	CN¥71.72 Million ≈ $10.49 Million	0.137x	+120.22%
2015-12-31	CN¥457.58 Million ≈ $66.96 Million	CN¥28.50 Million ≈ $4.17 Million	0.062x	+8.38%
2014-12-31	CN¥395.37 Million ≈ $57.86 Million	CN¥22.72 Million ≈ $3.33 Million	0.057x	-51.42%
2013-12-31	CN¥332.63 Million ≈ $48.67 Million	CN¥39.35 Million ≈ $5.76 Million	0.118x	+54.43%
2012-12-31	CN¥210.43 Million ≈ $30.79 Million	CN¥16.12 Million ≈ $2.36 Million	0.077x	--

About Shaanxi Kanghui Pharm Co Ltd

SHG:603139 China Drug Manufacturers - Specialty & Generic

Market Cap

$530.55 Million

CN¥3.63 Billion CNY

Market Cap Rank

#12233 Global

#3785 in China

Share Price

CN¥36.30

Change (1 day)

-1.31%

52-Week Range

CN¥19.40 - CN¥36.78

All Time High

CN¥41.00